Head-to-head · Cost-Efficiency Index
ShedRx (Shed) vs OlleveCare
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
ShedRx (Shed)
People who want a needle-free route or a brand-name option, and who will commit to twelve months to reach the lowest price.
Visit ShedRx (Shed)OlleveCare
Cost-first shoppers who want one-stop virtual care pairing GLP-1 with urgent care and refills.
Visit OlleveCareThe verdict
ShedRx (Shed) takes it, leading the Cost-Efficiency Index 87 to 43. The widest set of formats on the board — injection, drops, lozenges and a daily oral pill, plus a real brand Zepbound route — though its cheapest advertised rates need a year-long commitment. OlleveCare still earns a C — Cost-first shoppers who want one-stop virtual care pairing GLP-1 with urgent care and refills.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the board). See how it stacks up: CoreAge Rx vs ShedRx (Shed).
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | ShedRx (Shed) | OlleveCare |
|---|---|---|
| Cost-Efficiency Index | 87/100 | 43/100 |
| Semaglutide / mo | $199/mo ($159 on a 12-month plan) | Not disclosed |
| Tirzepatide / mo | $299/mo ($239 on a 12-month plan) | Not disclosed |
| Semaglutide / yr (modeled) | $2,388 | — |
| Tirzepatide / yr (modeled) | $3,588 | — |
| Coverage | All 50 states | 13 states |
| Oral / sublingual | Yes | No |
| Brand-name access | Yes | Compounded only |
| Rank on the board | #3 | #453 |
ShedRx (Shed)
87/100Where the value is
- Four routes to a GLP-1 — injection, liquid drops, lozenges and a daily oral pill
- Brand Zepbound and Wegovy available alongside the compounded line
- Available in all 50 states, with health coaching included and a published 120-day weight-loss guarantee
The tradeoffs
- The advertised "as low as" prices ($159 semaglutide, $239 tirzepatide) require a TWELVE-MONTH commitment — month-to-month is $199 and $299
- Compounded medication is not FDA-approved the way brand Ozempic, Wegovy, or Zepbound are
OlleveCare
43/100Where the value is
- 13 states listed explicitly (VA, FL, AZ, MA, HI, IA, MD, NM, WA, KS, NY, DC, ID)
- Both semaglutide and tirzepatide offered — switch molecules without switching platforms
- Multi-service platform — GLP-1, virtual urgent care, and non-controlled refills with one provider
The tradeoffs
- Legal entity name not disclosed anywhere — can't be verified in a state registry
- Pricing not shown before booking — you must enter the intake flow to see the fee
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.